CNS recurrence of primary mediastinal large b-cell lymphoma after complete remission

Journal of Neuro-Oncology

Volumn 95, Issue 1, 2009, Pages 135-139

  Stefoni, Vittorio ^a   Broccoli, Alessandro ^a   Pellegrini, Cinzia ^a   Derenzini, Enrico ^a   Fina, Mariapaola ^a   Zinzani, Pier Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FOLINIC ACID; METHOTREXATE; RITUXIMAB; VALACICLOVIR; VINCRISTINE;

ADULT; ARTICLE; ASTHENIA; B CELL LYMPHOMA; BLOOD TOXICITY; BONE MARROW BIOPSY; BRAIN HERNIA; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRANIOTOMY; DRUG MEGADOSE; DYSPNEA; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HERPES ZOSTER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MEDIASTINUM TUMOR; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SIDE EFFECT; THORAX RADIOGRAPHY; TUMOR BIOPSY;

FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MAGNETIC RESONANCE IMAGING; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, COMPLEMENT 3D; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; UBIQUITIN-PROTEIN LIGASES;

EID: 70349303760     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-9898-0     Document Type: Article

References (25)

1. Levitt LJ, Aisenberg AC, Harris NL et al (1982) Primary non-Hodgkin's lymphoma of the mediastinum. Cancer 50:2486-2492. doi: 10.1002/ 1097-0142(19821201)50:11<2486::AID-CNCR2820501138>3.0.CO;2-G
2. Lazzarino M, Orlandi E, Paulli M et al (1993) Primary mediastinal B-cell lymphoma with sclerosis: An aggressive tumor with distintive clinical and pathologic features. J Clin Oncol 11(12):2306-2313
3. Savage KJ (2006) Primary mediastinal large B-cell lymphoma. Oncologist 11:488-495. doi: 10.1634/theoncologist.11-5-488
4. Klimo P, Connors JM (1985) MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med 102:596-602
5. Hill QA, Owen RG (2006) CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Rev 20:319-332. doi: 10.1016/ j.blre.2006.02.001
6. Van Besien K, Ha CS, Murphy S et al (1998) Risk factors, treatment and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood 91:1178-1184
7. Zinzani PL, Magagnoli M, Frezza G et al (1999) Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: The Bologna experience. Leuk Lymphoma 32:571-576
8. Haioun C, Besson C, Lepage E et al (2000) Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients. Ann Oncol 11:685-690. doi: 10.1023/A:1008394827806
9. Hollender A, Kvaloy S, Nome O et al (2002) Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: A risk model. Ann Oncol 13:1099-1107. doi: 10.1093/annonc/mdf175
10. Boehme V, Zeynalova S, Kloess M et al (2007) Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL). Ann Oncol 18:149-157. doi: 10.1093/annonc/mdl327
11. Lister A, Abrey LE, Sandlund JT (2002) Central nervous system lymphoma. Hematology (Am Soc Hematol Educ Program):283-296. doi: 10.1182/ asheducation-2002.1.283
12. Van Besien K, Gisselbrecht C, Pfreundschuh M et al (2008) Secondary lymphomas of the central nervous system: Risk, prophylaxis and treatment. Leuk Lymphoma 49:52-58. doi: 10.1080/10428190802311458
13. Bishop PC, Wilson WH, Pearson D et al (1999) CNS involvement in primary mediastinal large B-cell lymphoma. J Clin Oncol 17:2479-2485
14. Martelli MP, Martelli M, Pescarmona E et al (1998) MACOP-B and involved field radiation therapy is an effective therapy for primary mediastinal large B-cell lymphoma with sclerosis. Ann Oncol 9:1027-1029. doi: 10.1023/A:1008412009667
15. Zinzani PL, Martelli M, De Renzo A et al (2001) Primary mediastinal large B-cell lymphoma with sclerosis: A clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy. Haematologica 86:187-191
16. Zinzani PL, Martelli M, Poletti V et al (2008) Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: Primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 93:1364-1371. doi: 10.3324/haematol.12742
17. Chua SL, Seymour JF, Streater J et al (2002) Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma. Leuk Lymphoma 43:1783. doi: 10.1080/1042819021000006475
18. Tomita N, Kodama F, Kanamori H et al (2002) Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-Hodgkin lymphoma. Cancer 95:576-580. doi: 10.1002/cncr.10699
19. Barosi G, Carella A, Lazzarino M et al (2006) Management of nodal diffuse large B-cell lymphomas: Practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Haematologica 91:96-103
20. Franklin JL, Finlay J (2006) Leukemias and lymphomas: Treatment and prophylaxis of the central nervous system. Curr Treat Options Neurol 8:335-345. doi: 10.1007/s11940-006-0023-9
21. Massenkeil G, Späth-Schwalbe E, Flath B et al (1998) Transient tetraparesis after intrathecal and high-dose systemic methotrexate. Ann Hematol 77:239-242. doi: 10.1007/s002770050450
22. Ferhanoglu B, Ongören S, Ar CM et al (2003) Intrathecal methotrexate-induced acute cerebellar syndrome. Ann Hematol 82:241-243
23. Dai MS, Ho CL, Chen YC et al (2000) Acute respiratory distress syndrome following intrathecal methotrexate administration: A case report and review of literature. Ann Hematol 79:696-699. doi: 10.1007/s002770000217
24. Benekli M, Güllü IH, Savaş MC et al (1996) Acute tumor lysis syndrome following intrathecal methotrexate. Leuk Lymphoma 22:361-363. doi: 10.3109/10428199609051770
25. Watterson J, Toogood I, Nieder M et al (1994) Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer 74:3034-3041. doi: 10.1002/ 1097-0142(19941201)74:11<3034::AID-CNCR2820741122>3.0.CO;2-O